Toshihiko Matsuo Takehiro Tanaka Osamu Yamasaki
10.1177/2324709619888052
J Investig Med High Impact Case Rep
2019 Jan-Dec;7:2324709619888052.
braf inhibitor braf mutation mek inhibitor pet/ct dabrafenib lacrimal sac malignant melanoma trametinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/31747798/
Eye Neoplasms / diagnosis Melanoma / diagnosis Nasolacrimal Duct / pathology Protein Kinase Inhibitors / therapeutic use Proto-Oncogene Proteins B-raf / genetics
Eye Neoplasms / diagnosis Melanoma / diagnosis Nasolacrimal Duct / pathology Protein Kinase Inhibitors / therapeutic use Proto-Oncogene Proteins B-raf / genetics Case Reports Review Aged Antineoplastic Combined Chemotherapy Protocols Eye Neoplasms / drug therapy Eye Neoplasms / genetics Humans Imidazoles Male Melanoma / drug therapy Melanoma / genetics Mutation Oximes Positron-Emission Tomography Proto-Oncogene Proteins B-raf / antagonists & inhibitors Pyridones Pyrimidinones Imidazoles Oximes Protein Kinase Inhibitors Pyridones Pyrimidinones trametinib BRAF protein, human Proto-Oncogene Proteins B-raf dabrafenib
PMC6873277
31747798
Lacrimal Sac Malignant Melanoma in 15 Japanese Patients: Case Report and Literature Review
2019